Intramuscular botulinum toxin a (BTXA) in complex regional pain syndrome

Siddharth Kharkar, Prakash Ambady, Venkatesh Yedatore, Robert Schwartzman

Research output: Contribution to journalReview article

6 Scopus citations

Abstract

Background: Pain associated with complex regional pain syndrome (CRPS) is frequently excruciating and intractable. The use of botulinum toxin for relief of CRPS-associated pain has not been well described. Objectives: To assess whether intramuscular botulinum toxin injections cause relief of pain caused by CRPS, and to assess the risks of this treatment. Study Design: Retrospective chart review. Setting: Outpatient clinic. Methods: Patients: 37 patients with spasm/dystonia in the neck and/or upper limb girdle muscles. Intervention: Electromyography-guided injection of botulinum toxin A (BtxA), 10-20 U per muscle. Total dose used was 100 U in each patient. Measurement: Local pain score on an 11 point Likert scale, 4 weeks after BtxA injections. Results: Mean pain score decreased by 43% (8.2 ± 0.8 to 4.5 ± 1.1, P < 0.001). Ninety-seven percent of the patients had significant pain relief. One patient had transient neck drop after the injections. Limitations: This is a retrospective study; it lacks a control group and therefore the placebo effect cannot be eliminated. This study does not provide information on the efficacy of this treatment after 4 weeks. Conclusion(s): Intramuscular injection of botulinum toxin A in the upper limb girdle muscles was beneficial for short term relief of pain caused by CRPS in this retrospective case series. The incidence of complications was low (2.7%).

Original languageEnglish (US)
Pages (from-to)311-316
Number of pages6
JournalPain Physician
Volume14
Issue number3
StatePublished - May 1 2011

Keywords

  • Botulinum toxin
  • Complex regional pain syndrome
  • Dystonia
  • Spasm

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Fingerprint Dive into the research topics of 'Intramuscular botulinum toxin a (BTXA) in complex regional pain syndrome'. Together they form a unique fingerprint.

  • Cite this

    Kharkar, S., Ambady, P., Yedatore, V., & Schwartzman, R. (2011). Intramuscular botulinum toxin a (BTXA) in complex regional pain syndrome. Pain Physician, 14(3), 311-316.